5 completed, 2 recruiting, 1 unknown, 1 withdrawn. 6 Phase 4, 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 4, Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Recruiting 2 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow lipoarabinomannan: new trials by email Literature Review of lipoarabinomannan trials Research Report on lipoarabinomannan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous BMA vs Saline and LAM + LP-PRP vs Saline Evaluations in Knee OA Bone Marrow Aspirate (BMA): Minimally manipulated autologous cellular preparation, Saline (Placebo Comparator for BMA), Lipoaspirate Micronized + Leukocyte-Poor Platelet-Rich Plasma (LAM + LP-PRP): Minimally manipulated autologous cellular preparations - Osteoarthritis, Knee | Phase 2 / Phase 3 | Recruiting | University Health Network, Toronto | 148 | 2025-01-01 | 2026-08-27 |
| Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability Bryophyllum 50 % Chewing Tablets - Anxiety Symptoms | Phase 4 | Completed | Markus Schlemmer | 51 | 2021-08-31 | 2024-06-21 |
| Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer Atezolizumab, Carboplatin, Etoposide - Extensive Stage Lung Small Cell Carcinoma | Phase 2 | Recruiting | Roswell Park Cancer Institute | 28 | 2021-07-02 | 2025-12-15 |
| An Exploratory Study of RGT Strategy on Optimal NUC-experienced Patients Peginterferon alfa-2a plus Entecavir, Peginterferon alfa-2a plus Lamivudine, Peginterferon alfa-2a plus Adefovir - Chronic Hepatitis B | Phase 4 | Unknown | Ruijin Hospital | 324 | 2015-05-01 | 2015-09-25 |
| Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B Telbivudine, Lamivudine - Chronic Hepatitis B, Late Pregnancy | Phase 4 | Completed | Beijing YouAn Hospital | 700 | 2009-01-01 | 2013-07-30 |
| Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI Lamotrigine, Placebo (for Lamotrigine) - Facial Neuropathy | Not applicable | Completed | Pain and Analgesia Imaging and Neuroscience Group | 6 | 2005-10-01 | 2018-12-07 |
| Maintenance Treatment of Bipolar Depression Lamotrigine, Divalproex (DIV) ER, Placebo - Bipolar Disorder, Depression | Phase 4 | Completed | The University of Texas Health Science Center at San Antonio | 86 | 2004-12-01 | 2017-05-17 |
| Tenofovir in HIV/HBV Coinfection Tenofovir, Zidovudine (AZT), lamivudine (LAM), efavirenz (EFV) - HIV Infection, Hepatitis B Coinfection | Phase 4 | Completed | Kirby Institute | 36 | 2004-01-01 | 2015-04-01 |
| Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B Lamivudine, Telbivudine - Hepatitis B, Chronic | Phase 4 | Withdrawn | University of Ulm | 40 | 2009-04-20 |
Hepatitis B, Chronic (3) · Depression (2) · Pain (2) · Anxiety Disorders (1) · Bipolar Disorder (1) · Facial Nerve Diseases (1) · Facies (1) · HIV Infections (1) · Hepatitis B (1) · Osteoarthritis, Knee (1) · Sleep Initiation and Maintenance Disorders (1)
Beijing YouAn Hospital (1) · Kirby Institute (1) · Markus Schlemmer (1) · Pain and Analgesia Imaging and Neuroscience Group (1) · Roswell Park Cancer Institute (1) · Ruijin Hospital (1) · The University of Texas Health Science Center at San Antonio (1) · University Health Network, Toronto (1) · University of Ulm (1)
United States (2) · Australia (1) · Canada (1) · China (1) · Germany (1) · Switzerland (1) · Thailand (1)
Calvin Pan, MD (1) · Charles L. Bowden, MD (1) · Christian Veillette, MD, MSc, FRCSC (1) · Christopher Kim, HBSc, MSc, MD, FRCSC, PhD(c) (1) · David Borsook, M.D., Ph.D. (1) · Grace K Dy (1) · Greg Dore, MBBS, FRACP (1) · Hua Zhang, MD (1) · Markus Schlemmer, Dr. med. (1) · Nektarios Dikopoulos, MD (1) · Sowmya Viswanathan, PhD (1)
PMID 18697216, PMID 20492571, PMID 22405335, PMID 22708645, PMID 25187919
P20MH068662 (1)